Pfizer's Paxlovid not included in China's national insurance
China's health care authorities declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive.
Published 5 months ago · Beijing, China
News Articles
More Filters
All
Left
Center
Right
Time & Location
Sources are mostly out of (0)